Fulgent Genetics Cost of Goods Sold 2015-2024 | FLGT

Fulgent Genetics cost of goods sold from 2015 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
Fulgent Genetics Annual Cost of Goods Sold
(Millions of US $)
2023 $185
2022 $252
2021 $216
2020 $90
2019 $14
2018 $11
2017 $9
2016 $7
2015 $5
2014 $1
Fulgent Genetics Quarterly Cost of Goods Sold
(Millions of US $)
2024-06-30 $45
2024-03-31 $42
2023-12-31 $45
2023-09-30 $45
2023-06-30 $47
2023-03-31 $47
2022-12-31 $55
2022-09-30 $60
2022-06-30 $60
2022-03-31 $78
2021-12-31 $62
2021-09-30 $43
2021-06-30 $36
2021-03-31 $74
2020-12-31 $52
2020-09-30 $26
2020-06-30 $8
2020-03-31 $4
2019-12-31 $4
2019-09-30 $4
2019-06-30 $4
2019-03-31 $3
2018-12-31 $3
2018-09-30 $3
2018-06-30 $3
2018-03-31 $3
2017-12-31 $3
2017-09-30 $2
2017-06-30 $2
2017-03-31 $2
2016-12-31 $2
2016-09-30 $2
2016-06-30 $1
2016-03-31 $1
2015-12-31
2015-09-30 $1
2015-06-30
2014-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.589B $0.289B
Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $11.384B 0.00
Inspire Medical Systems (INSP) United States $5.892B 183.76
Hims & Hers Health (HIMS) United States $5.028B 130.06
Axonics (AXNX) United States $3.600B 1760.50
IRhythm Technologies (IRTC) United States $2.707B 0.00
Enovis (ENOV) United States $2.594B 17.58
Privia Health (PRVA) United States $2.547B 213.00
Omnicell (OMCL) United States $2.306B 75.97
Azenta (AZTA) United States $2.190B 124.39
10x Genomics (TXG) United States $1.893B 0.00
Clover Health Investments (CLOV) United States $1.696B 0.00
Schrodinger (SDGR) United States $1.365B 0.00
Phreesia (PHR) United States $1.228B 0.00
Standard BioTools (LAB) United States $0.800B 0.00
Butterfly Network (BFLY) United States $0.558B 0.00
Talkspace (TALK) United States $0.555B 0.00
Definitive Healthcare (DH) United States $0.500B 84.80
Health Catalyst (HCAT) United States $0.498B 0.00
Pulmonx (LUNG) United States $0.294B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.230B 0.00
TruBridge (TBRG) United States $0.203B 58.91
American Well (AMWL) United States $0.135B 0.00
P3 Health Partners (PIII) United States $0.134B 0.00
EUDA Health Holdings (EUDA) Singapore $0.108B 0.00
HeartBeam (BEAT) United States $0.068B 0.00
Future Health ESG (FHLT) United States $0.065B 0.00
111 (YI) China $0.059B 0.00
Zepp Health (ZEPP) China $0.049B 0.00
SHL Telemedicine (SHLT) Israel $0.045B 0.00
CareCloud (CCLD) United States $0.044B 0.00
Outset Medical (OM) United States $0.040B 0.00
Movano (MOVE) United States $0.029B 0.00
Bullfrog AI Holdings (BFRG) United States $0.021B 0.00
MSP Recovery (LIFW) United States $0.018B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.013B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Precipio (PRPO) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.008B 0.00
Healthcare Triangle (HCTI) United States $0.007B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Syra Health (SYRA) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
HeartSciences (HSCS) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00